ClinicalTrials.govpublic full text
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
glucose metabolism disorders, diabetes mellitus, type 2, hypoglycemic agents, empagliflozin
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 143729
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.